368 Participants Needed

Communication & Screening Intervention for Lung Cancer

RM
Overseen ByRandi M Williams, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Georgetown University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Provider Prompt & Patient Outreach and Education for lung cancer?

Research shows that good communication between doctors and lung cancer patients improves patient satisfaction and understanding of their condition. Additionally, providing patients with more information can enhance their quality of life and satisfaction with care.12345

How does this lung cancer screening intervention differ from other treatments?

This lung cancer screening intervention is unique because it focuses on improving communication and education about screening, using both print and web-based materials to engage participants and increase awareness. It also adapts to different delivery modes, such as in-person and phone sessions, to effectively reach diverse populations and improve screening adherence.26789

Eligibility Criteria

This trial is for English-speaking individuals aged 50-80 who currently smoke or quit within the last 15 years, have a history of heavy smoking (20+ pack-years), and haven't had lung screening in over 13 months. They must be scheduled for an upcoming clinic appointment and able to consent and complete interviews. Those with a history of lung cancer cannot participate.

Inclusion Criteria

You have smoked the equivalent of one pack of cigarettes every day for at least 20 years.
I have a clinic appointment scheduled within the next 4 to 8 weeks.
Able and willing to provide meaningful consent and complete telephone interviews
See 4 more

Exclusion Criteria

I have a history of lung cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants and providers engage in a multilevel intervention to address health disparities in lung cancer screening

6 months
Regular visits as per clinic schedule

Follow-up

Participants are monitored for lung cancer screening knowledge, intentions, and completion rates

6 months
1 visit (in-person) at 1-week post-visit, ongoing monitoring

Treatment Details

Interventions

  • Provider Prompt & Patient Outreach and Education
Trial Overview The study is examining the effectiveness of two strategies: 'Provider Prompt' which reminds healthcare providers to discuss lung cancer screening, and 'Patient Outreach & Education' aimed at increasing patient knowledge about screening benefits.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Multilevel InterventionExperimental Treatment1 Intervention
Group II: Nonequivalent Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Georgetown University

Lead Sponsor

Trials
355
Recruited
142,000+

Findings from Research

A study involving 276 lung cancer patients revealed that many reported inadequate communication with their physicians on critical topics, such as emotional symptoms (56% reported low communication) and living will preparation (90% reported low communication).
Inadequate communication was consistent across different patient demographics, but Hispanic patients were less likely to report poor communication compared to non-Hispanic whites and blacks, indicating a potential area for improvement in patient care.
Patients rate physician communication about lung cancer.Nelson, JE., Gay, EB., Berman, AR., et al.[2022]
A study of 101 newly diagnosed lung cancer patients revealed that while most patients (86%) understood their diagnosis and 81% recalled their treatment procedure, only 42% were aware of whether their treatment goal was curative or palliative.
Patient satisfaction with communication was high for diagnosis (83%) and treatment procedure (77%), but significantly lower for treatment goals (53%), indicating a need for improved communication strategies, especially regarding treatment objectives.
Physician communication in a lung cancer center--does the message come across?Nehls, W., Gabrijel, S., Kiss, A., et al.[2015]
In a study of 200 lung cancer patients, those who received multimodal health education combined with a feedback method experienced significantly shorter postoperative extubation times and quicker recovery to leaving the bed compared to those who received conventional education.
Patients in the observation group also reported higher exercise compliance and greater satisfaction with their care, indicating that this educational approach can enhance recovery and improve psychological well-being after surgery.
Effect of Multimodal Health Education Combined with the Feedback Method in Perioperative Patients with Lung Cancer: A Randomised Controlled Study.Yuan, Z., Gao, L., Zheng, M., et al.[2023]

References

Patients rate physician communication about lung cancer. [2022]
Physician communication in a lung cancer center--does the message come across? [2015]
Effect of Multimodal Health Education Combined with the Feedback Method in Perioperative Patients with Lung Cancer: A Randomised Controlled Study. [2023]
Development of a Cancer Care Summary Through the Electronic Health Record. [2016]
Impact of information on quality of life and satisfaction of non-small cell lung cancer patients: a randomized study of standardized versus individualized information before thoracic surgery. [2015]
Tobacco treatment specialists' knowledge, attitudes and beliefs about lung cancer screening: Potential piece of the puzzle for increasing lung cancer screening awareness. [2023]
The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial. [2023]
Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery. [2023]
Patient vs Clinician Perspectives on Communication About Results of Lung Cancer Screening: A Qualitative Study. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security